Kissei Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3240600001
JPY
4,000.00
-10 (-0.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
24,773.00
26,802.00
23,640.00
22,191.00
22,661.00
23,203.00
21,302.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
24,773.00
26,802.00
23,640.00
22,191.00
22,661.00
23,203.00
21,302.00
Raw Material Cost
13,946.00
14,498.00
12,032.00
11,111.00
11,714.00
11,483.00
10,785.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.00
7.00
7.00
6.00
6.00
6.00
5.00
Selling and Distribution Expenses
10,071.00
9,149.00
20,554.00
8,971.00
6,617.00
9,264.00
6,388.00
Other Expenses
-0.80
-0.70
-0.70
-0.60
278.80
-0.60
450.00
Total Expenditure (Excl Depreciation)
24,017.00
23,647.00
32,586.00
20,082.00
21,125.00
20,747.00
21,678.00
Operating Profit (PBDIT) excl Other Income
756
3155
-8946
2109
1536
2456
-376
Other Income
2,419.00
1,257.00
11,963.00
3,530.00
2,739.00
4,691.00
2,194.00
Operating Profit (PBDIT)
4,369.00
5,608.00
4,183.00
6,727.00
5,435.00
8,320.00
2,979.00
Interest
8.00
7.00
7.00
6.00
6.00
6.00
5.00
Exceptional Items
117.00
-211.00
654.00
116.00
-231.00
-2,727.00
-175.00
Gross Profit (PBDT)
10,827.00
12,304.00
11,608.00
11,080.00
10,947.00
11,720.00
10,517.00
Depreciation
1,194.00
1,196.00
1,166.00
1,088.00
1,160.00
1,173.00
1,161.00
Profit Before Tax
3,284.00
4,197.00
3,663.00
5,747.00
4,036.00
4,415.00
1,638.00
Tax
482.00
916.00
305.00
1,227.00
915.00
813.00
490.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,764.00
3,230.00
3,266.00
4,519.00
3,121.00
3,590.00
1,144.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,764.00
3,230.00
3,266.00
4,519.00
3,121.00
3,590.00
1,144.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
37.00
51.00
92.00
1.00
0.00
12.00
3.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,801.00
3,281.00
3,358.00
4,520.00
3,121.00
3,602.00
1,147.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,30,146.00
2,16,392.00
2,11,380.00
2,07,087.00
2,09,004.00
2,10,203.00
2,19,657.00
Earnings per share (EPS)
66.7
77.92
78.76
107.87
72.91
82.65
25.86
Diluted Earnings per share
66.7
77.92
78.76
107.87
72.91
82.65
25.86
Operating Profit Margin (Excl OI)
3.05%
11.77%
-37.84%
9.5%
6.78%
10.58%
-1.77%
Gross Profit Margin
18.08%
20.12%
20.43%
30.8%
22.93%
24.08%
13.14%
PAT Margin
11.16%
12.05%
13.82%
20.36%
13.77%
15.47%
5.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 9.32% vs 27.88% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -10.25% vs 10.01% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -27.67% vs 172.32% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 33.33% vs 20.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Kissei Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
24,773.00
13,197.00
11,576.00
87.72%
Other Operating Income
0.00
0.00
0.00
Total Operating income
24,773.00
13,197.00
11,576.00
87.72%
Raw Material Cost
13,946.00
4,204.00
9,742.00
231.73%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.00
154.00
-146.00
-94.81%
Selling and Distribution Expenses
10,071.00
7,899.00
2,172.00
27.50%
Other Expenses
-0.80
10.20
-11.00
-107.84%
Total Expenditure (Excl Depreciation)
24,017.00
12,359.00
11,658.00
94.33%
Operating Profit (PBDIT) excl Other Income
756.00
838.00
-82.00
-9.79%
Other Income
2,419.00
100.00
2,319.00
2,319.00%
Operating Profit (PBDIT)
4,369.00
1,745.00
2,624.00
150.37%
Interest
8.00
154.00
-146.00
-94.81%
Exceptional Items
117.00
0.00
117.00
Gross Profit (PBDT)
10,827.00
8,993.00
1,834.00
20.39%
Depreciation
1,194.00
807.00
387.00
47.96%
Profit Before Tax
3,284.00
782.00
2,502.00
319.95%
Tax
482.00
428.00
54.00
12.62%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,764.00
-32.00
2,796.00
8,737.50%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,764.00
-32.00
2,796.00
8,737.50%
Share in Profit of Associates
0
0
0.00
Minority Interest
37.00
385.00
-348.00
-90.39%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,801.00
353.00
2,448.00
693.48%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,30,146.00
32,839.00
1,97,307.00
600.83%
Earnings per share (EPS)
66.70
-0.23
66.93
29,100.00%
Diluted Earnings per share
66.70
-0.23
66.93
29,100.00%
Operating Profit Margin (Excl OI)
3.05%
6.35%
0.00
-3.30%
Gross Profit Margin
18.08%
12.04%
0.00
6.04%
PAT Margin
11.16%
-0.24%
0.00
11.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,477.30 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -7.57% vs 13.38% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 9.32% vs 27.88% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 280.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -14.63% vs -2.29% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -10.25% vs 10.01% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 195.00 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -55.18% vs 155.93% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -27.67% vs 172.32% in Mar 2025

Quarterly - Interest
Interest 0.80 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 14.29% vs 0.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 33.33% vs 20.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.05%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025